Duriez, Patrick

Atherogenic Lipoprotein Particles in Atherosclerosis

Carmena, R., Duriez, P., & Fruchart, J.-C. (2004) · Circulation

Lipoproteins and Cardiovascular HealthCholesterol and Lipid Metabolism

Cited by 494

Peroxisome proliterator-activated receptor-alpha activators regulate genes governing lipoprotein metabolism, vascular inflammation and atherosclerosis

Fruchart, J.-C., Duriez, P., & Staels, B. (1999) · Current Opinion in Lipidology

Peroxisome Proliferator-Activated ReceptorsCholesterol and Lipid Metabolism

Cited by 425

The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential: A consensus statement from the International Atherosclerosis Society (IAS) and the Residual Risk Reduction Initiative (R3i) Foundation

Fruchart, J.-C., Santos, R. D., Aguilar-Salinas, C., Aikawa, M., Al Rasadi, K., Amarenco, P., Barter, P. J., Ceska, R., Corsini, A., Després, J.-P., et al. (2019) · Cardiovascular Diabetology

Peroxisome Proliferator-Activated ReceptorsLipoproteins and Cardiovascular Health

Cited by 140

4-Mercaptoimidazoles Derived From the Naturally Occurring Antioxidant Ovothiols 1. Antioxidant Properties

Zoete, V., Bailly, F., Vezin, H., Teissier, E., Duriez, P., Fruchart, J.-C., Catteau, J.-P., & Bernier, J.-L. (2000) · Free Radical Research

Free Radicals and AntioxidantsAntioxidant Activity and Oxidative Stress

Cited by 27

Antioxydant activity of β-carboline derivatives in the LDL oxidation model

Hadjaz, F., Besret, S., Martin-Nizard, F., Yous, S., Dilly, S., Lebegue, N., Chavatte, P., Duriez, P., Berthelot, P., & Carato, P. (2011) · European Journal of Medicinal Chemistry

Synthesis and bioactivity of alkaloidsAntioxidant Activity and Oxidative Stress

Cited by 21